Santa Cruz Biotechnology supplies a comprehensive collection of ACT Antibodies for targeting the actin cytoskeleton. ACT Antibodies are validated for multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Actin plays a crucial role in maintaining cell shape, enabling cellular movement, and facilitating intracellular transport. The dynamic nature of actin is essential for processes such as muscle contraction, cell division, and signal transduction. Understanding actin biology is fundamental for research in cell motility, development, and disease progression. ACT Antibodies enable detailed investigation of cytoskeletal organization and dynamics across diverse cellular processes. Researchers can visualize and analyze actin distribution patterns in various cell types and experimental conditions. ACT Antibodies support precise detection and quantification of actin expression levels in different tissues and developmental stages. Santa Cruz Biotechnology monoclonal antibodies for ACT detection contribute to advancing scientific understanding of cellular mechanics and disease mechanisms.